Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 858496, 12 pages
http://dx.doi.org/10.1155/2014/858496
Review Article

The Harmful Effects of Subarachnoid Hemorrhage on Extracerebral Organs

1Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
2Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA
3Department of Neurology, The Fifth People’s Hospital, Chongqing 400011, China

Received 18 February 2014; Revised 5 May 2014; Accepted 6 May 2014; Published 7 July 2014

Academic Editor: Chih-Lung Lin

Copyright © 2014 Sheng Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Kingwell, “Stroke: improving the management of patients at risk of haemorrhagic stroke,” Nature Reviews Neurology, vol. 10, article 1, 2014. View at Publisher · View at Google Scholar
  2. M. H. Li, S. W. Chen, Y. D. Li et al., “Prevalence of unruptured cerebral aneurysms in Chinese adults aged 35 to 75 years: a cross-sectional study,” Annals of Internal Medicine, vol. 159, no. 8, pp. 514–521, 2013. View at Google Scholar
  3. B. E. Zacharia, Z. L. Hickman, B. T. Grobelny et al., “Epidemiology of aneurysmal subarachnoid hemorrhage,” Neurosurgery Clinics of North America, vol. 21, no. 2, pp. 221–233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Chen, H. Feng, P. Sherchan et al., “Controversies and evolving new mechanisms in subarachnoid hemorrhage,” Progress in Neurobiology, vol. 115, pp. 64–91, 2014. View at Google Scholar
  5. E. S. Connolly Jr., A. A. Rabinstein, J. R. Carhuapoma et al., “Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 43, no. 6, pp. 1711–1737, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. P. Ostrowski and J. H. Zhang, “Hyperbaric oxygen for cerebral vasospasm and brain injury following subarachnoid hemorrhage,” Translational Stroke Research, vol. 2, no. 3, pp. 316–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Shimamura and H. Ohkuma, “Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage,” Translational Stroke Research, vol. 5, no. 3, pp. 357–364, 2013. View at Publisher · View at Google Scholar
  8. M. Fujii, J. Yan, W. B. Rolland, Y. Soejima, B. Caner, and J. H. Zhang, “Early brain Injury, an evolving frontier in subarachnoid hemorrhage research,” Translational Stroke Research, vol. 4, no. 4, pp. 432–446, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Dupont and A. A. Rabinstein, “Extent of acute hydrocephalus after subarachnoid hemorrhage as a risk factor for poor functional outcome,” Neurological Research, vol. 35, no. 2, pp. 107–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. N. J. Solenski, E. C. Haley Jr., N. F. Kassell et al., “Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study,” Critical Care Medicine, vol. 23, no. 6, pp. 1007–1017, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. M. T. Wybraniec, K. Mizia-Stec, and L. J. Krzych, “Neurocardiogenic injury in subarachnoid hemorrhage: a wide spectrum of catecholamine-mediated brain-heart interactions,” Cardiology Journal, 2014. View at Publisher · View at Google Scholar
  12. D. L. Davison, L. S. Chawla, L. Selassie, R. Tevar, C. Junker, and M. G. Seneff, “Neurogenic pulmonary edema: successful treatment with IV phentolamine,” Chest, vol. 141, no. 3, pp. 793–795, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Naredi, G. Lambert, E. Edén et al., “Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage,” Stroke, vol. 31, no. 4, pp. 901–906, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Fassot, G. Lambert, J. L. Elghozi, and E. Lambert, “Impact of the renin-angiotensin system on cerebral perfusion following subarachnoid haemorrhage in the rat,” Journal of Physiology, vol. 535, no. 2, pp. 533–540, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Sugimoto, J. Inamasu, Y. Kato et al., “Association between elevated plasma norepinephrine levels and cardiac wall motion abnormality in poor-grade subarachnoid hemorrhage patients,” Neurosurgical Review, vol. 36, no. 2, pp. 259–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Lambert, S. Naredi, E. Edén, B. Rydenhag, and P. Friberg, “Sympathetic nervous activation following subarachnoid hemorrhage: influence of intravenous clonidine,” Acta Anaesthesiologica Scandinavica, vol. 46, no. 2, pp. 160–165, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Inamasu, Y. Nakamura, R. Saito et al., “Normokalemia and hyperglycemia in subarachnoid hemorrhage patients resuscitated from prehospital cardiopulmonary arrest,” Resuscitation, vol. 54, no. 3, pp. 255–258, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. P. I. Johansson, N. Haase, A. Perner, and S. R. Ostrowski, “Association between sympathoadrenal activation, fibrinolysis, and endothelial damage in septic patients: a prospective study,” Journal of Critical Care, vol. 29, no. 3, pp. 327–333, 2014. View at Publisher · View at Google Scholar
  19. P. K. Yeung, J. Shen, S. S. Chung, and S. K. Chung, “Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage,” BMC Neuroscience, vol. 14, article 131, 2013. View at Publisher · View at Google Scholar
  20. J. Bellapart, L. Jones, H. Bandeshe, and R. Boots, “Plasma endothelin-1 as screening marker for cerebral vasospasm after subarachnoid hemorrhage,” Neurocritical Care, vol. 20, no. 1, pp. 77–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. R. L. MacDonald, R. T. Higashida, E. Keller et al., “Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling,” Stroke, vol. 43, no. 6, pp. 1463–1469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. L. Macdonald, R. T. Higashida, E. Keller et al., “Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2),” The Lancet Neurology, vol. 10, no. 7, pp. 618–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Sugimoto, J. Inamasu, Y. Hirose et al., “The role of norepinephrine and estradiol in the pathogenesis of cardiac wall motion abnormality associated with subarachnoid hemorrhage,” Stroke, vol. 43, no. 7, pp. 1897–1903, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. M. Mertes, J. P. Carteaux, Y. Jaboin et al., “Estimation of myocardial interstitial norepinephrine release after brain death using cardiac microdialysis,” Transplantation, vol. 57, no. 3, pp. 371–377, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. E. A. Espiner, R. Leikis, R. D. Ferch et al., “The neuro-cardio-endocrine response to acute subarachnoid haemorrhage,” Clinical Endocrinology, vol. 56, no. 5, pp. 629–635, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Berendes, M. Walter, P. Cullen et al., “Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage,” The Lancet, vol. 349, no. 9047, pp. 245–249, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Papanikolaou, D. Makris, D. Karakitsos et al., “Cardiac and central vascular functional alterations in the acute phase of aneurysmal subarachnoid hemorrhage,” Critical Care Medicine, vol. 40, no. 1, pp. 223–232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Okuchi, M. Fujioka, A. Fujikawa et al., “Rapid natriuresis and preventive hypervolaemia for symptomatic vasospasm after subarachnoid haemorrhage,” Acta Neurochirurgica, vol. 138, no. 8, pp. 951–956, 1996. View at Google Scholar
  29. T. Igarashi, N. Moro, Y. Katayama, T. Mori, J. Kojima, and T. Kawamata, “Prediction of symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage: Relationship to cerebral salt wasting syndrome,” Neurological Research, vol. 29, no. 8, pp. 835–841, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Kojima, Y. Katayama, N. Moro, H. Kawai, M. Yoneko, and T. Mori, “Cerebral salt wasting in subarachnoid hemorrhage rats: model, mechanism, and tool,” Life Sciences, vol. 76, no. 20, pp. 2361–2370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Fassot, G. Lambert, E. Gaudet-Lambert, P. Friberg, and J. L. Elghozi, “Beneficial effect of renin-angiotensin system for maintaining blood pressure control following subarachnoid haemorrhage,” Brain Research Bulletin, vol. 50, no. 2, pp. 127–132, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Neil-Dwyer, P. Walter, H. J. H. Shaw, R. Doshi, and M. Hodge, “Plasma renin activity in patients after a subarachnoid hemorrhage—a possible predictor of outcome,” Neurosurgery, vol. 7, no. 6, pp. 578–582, 1980. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Hamann, E. Isenberg, M. Stoll, G. Huber, M. Strittmatter, and K. Schimrigk, “Renin activation correlates with blood amount and distribution in subarachnoid haemorrhage,” NeuroReport, vol. 4, no. 5, pp. 595–598, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Audibert, G. Steinmann, N. de Talancé et al., “Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation,” Anesthesia and Analgesia, vol. 108, no. 6, pp. 1922–1928, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. V. C. Biancardi, S. J. Son, S. Ahmadi, J. A. Filosa, and J. E. Stern, “Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier,” Hypertension, vol. 63, no. 3, pp. 572–579, 2014. View at Google Scholar
  36. N. Pelisch, N. Hosomi, M. Ueno et al., “Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in dahl salt-sensitive hypertensive rats,” American Journal of Hypertension, vol. 24, no. 3, pp. 362–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Honda, H. Minato, B. Fujitani, Y. Masuda, and K. Hosoki, “Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 19, no. 10, pp. 699–706, 1997. View at Google Scholar · View at Scopus
  38. J. M. Simard, C. Tosun, S. Ivanova et al., “Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage,” Translational Stroke Research, vol. 3, supplement 1, pp. 155–165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Commichau, N. Scarmeas, and S. A. Mayer, “Risk factors for fever in the neurologic intensive care unit,” Neurology, vol. 60, no. 5, pp. 837–841, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Yoshimoto, Y. Tanaka, and K. Hoya, “Acute systemic inflammatory response syndrome in subarachnoid hemorrhage,” Stroke, vol. 32, no. 9, pp. 1989–1993, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Dhar and M. N. Diringer, “The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage,” Neurocritical Care, vol. 8, no. 3, pp. 404–412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. T. A. Hassen, S. Pearson, P. A. Cowled, and R. A. Fitridge, “Preoperative nutritional status predicts the severity of the systemic inflammatory response syndrome (SIRS) following major vascular surgery,” European Journal of Vascular and Endovascular Surgery, vol. 33, no. 6, pp. 696–702, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. K. E. Wartenberg, J. M. Schmidt, J. Claassen et al., “Impact of medical complications on outcome after subarachnoid hemorrhage,” Critical Care Medicine, vol. 34, no. 3, pp. 617–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Gruber, A. Reinprecht, U. M. Illievich et al., “Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage,” Critical Care Medicine, vol. 27, no. 3, pp. 505–514, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. D. E. Spratt, V. K. Reddy, A. A. Choxi et al., “Dexamethasone significantly attenuates subarachnoid hemorrhage-induced elevation in cerebrospinal fluid citrulline and leukocytes,” Journal of Neurosurgical Sciences, vol. 56, no. 4, pp. 363–371, 2012. View at Google Scholar · View at Scopus
  46. S. E. Hocker, L. Tian, G. Li, J. M. Steckelberg, J. N. Mandrekar, and A. A. Rabinstein, “Indicators of central fever in the neurologic intensive care unit,” JAMA Neurology, vol. 70, no. 12, pp. 1499–1504, 2013. View at Google Scholar
  47. R. D. Rothoerl, C. Axmann, A. Pina, C. Woertgen, and A. Brawanski, “Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgical Anesthesiology, vol. 18, no. 1, pp. 68–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. M. M. Levy, M. P. Fink, J. C. Marshall et al., “2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference,” Intensive Care Medicine, vol. 29, no. 4, pp. 530–538, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Kitamura, M. Nomura, H. Shima et al., “Acute lung injury associated with systemic inflammatory response syndrome following subarachnoid hemorrhage: a survey by the shonan neurosurgical association,” Neurologia Medico-Chirurgica, vol. 50, no. 6, pp. 456–460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Braunwald and R. A. Kloner, “The stunned myocardium: Prolonged, postischemic ventricular dysfunction,” Circulation, vol. 66, no. 6, pp. 1146–1149, 1982. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Ahmadian, A. Mizzi, M. Banasiak et al., “Cardiac manifestations of subarachnoid hemorrhage,” Heart, Lung and Vessels, vol. 5, no. 3, pp. 168–178, 2013. View at Google Scholar
  52. G. M. Ibrahim and R. L. MacDonald, “Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage,” Stroke, vol. 43, no. 8, pp. 2102–2107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. M. B. Skrifvars and M. J. Parr, “Incidence, predisposing factors, management and survival following cardiac arrest due to subarachnoid haemorrhage: a review of the literature,” Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, vol. 20, article 75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Franco, B. Khaled, L. Afonso, and M. Raufi, “Acute subarachnoid hemorrhage and cardiac abnormalities: takotsubo cardiomyopathy or neurogenic stunned myocardium? A case report,” Cases Journal, vol. 3, p. 81, 2010. View at Google Scholar
  55. H. J. Priebe, “Aneurysmal subarachnoid haemorrhage and the anaesthetist,” British Journal of Anaesthesia, vol. 99, no. 1, pp. 102–118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Doshi and G. Neil-Dwyer, “Hypothalamic and myocardial lesions after subarachnoid haemorrhage,” Journal of Neurology Neurosurgery & Psychiatry, vol. 40, no. 8, pp. 821–826, 1977. View at Publisher · View at Google Scholar · View at Scopus
  57. J. G. Zaroff, J. Leong, H. Kim et al., “Cardiovascular predictors of long-term outcomes after non-traumatic subarachnoid hemorrhage.,” Neurocritical Care, vol. 17, no. 3, pp. 374–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. P. J. A. M. Brouwers, H. G. M. Westenberg, and J. van Gijn, “Noradrenaline concentrations and electrocardiographic abnormalities after aneurysmal subarachnoid haemorrhage,” Journal of Neurology Neurosurgery and Psychiatry, vol. 58, no. 5, pp. 614–617, 1995. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Švigelj, A. Grad, and T. Kiauta, “Heart rate variability, norepinephrine and ECG changes in subarachnoid hemorrhage patients,” Acta Neurologica Scandinavica, vol. 94, no. 2, pp. 120–126, 1996. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Chatterjee, “ECG changes in subarachnoid haemorrhage: a synopsis,” Netherlands Heart Journal, vol. 19, no. 1, pp. 31–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. M. D. Aydin, A. Kanat, A. Yilmaz et al., “The role of ischemic neurodegeneration of the nodose ganglia on cardiac arrest after subarachnoid hemorrhage: an experimental study,” Experimental Neurology, vol. 230, no. 1, pp. 90–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. J. M. Schmidt, M. Crimmins, H. Lantigua et al., “Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage,” Neurocritical Care, vol. 20, no. 3, pp. 390–398, 2014. View at Publisher · View at Google Scholar
  63. S. Park, F. Kaffashi, K. A. Loparo, and F. J. Jacono, “The use of heart rate variability for the early detection of treatable complications after aneurysmal subarachnoid hemorrhage,” Journal of Clinical Monitoring and Computing, vol. 27, no. 4, pp. 385–393, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. T. F. Chiu, C. C. Huang, J. H. Chen, and W. L. Chen, “Depressed sympathovagal balance predicts mortality in patients with subarachnoid hemorrhage,” The American Journal of Emergency Medicine, vol. 30, no. 5, pp. 651–656, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. J. M. Schmidt, D. Sow, M. Crimmins et al., “Heart rate variability for preclinical detection of secondary complications after subarachnoid hemorrhage,” Neurocritical Care, vol. 20, no. 3, pp. 382–389, 2014. View at Publisher · View at Google Scholar
  66. S. Fukui, H. Katoh, N. Tsuzuki et al., “Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage,” Critical Care, vol. 7, no. 3, pp. R7–R12, 2003. View at Publisher · View at Google Scholar
  67. T. Ichinomiya, Y. Terao, K. Miura et al., “QTc interval and neurological outcomes in aneurysmal subarachnoid hemorrhage,” Neurocritical Care, vol. 13, no. 3, pp. 347–354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Kuroiwa, H. Morita, H. Tanabe, and T. Ohta, “Significance of ST segment elevation in electrocardiograms in patients with ruptured cerebral aneurysms,” Acta Neurochirurgica, vol. 133, no. 3-4, pp. 141–146, 1995. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Kolin and J. W. Norris, “Myocardial damage from acute cerebral lesions,” Stroke, vol. 15, no. 6, pp. 990–993, 1984. View at Publisher · View at Google Scholar · View at Scopus
  70. Q. Liu, Y. Ding, J. H. Zhang, and H. Lei, “ECG change of acute subarachnoid hemorrhagic patients,” Acta Neurochirurgica, Supplementum, no. 111, pp. 357–359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. C. C. Huang, C. H. Huang, H. Y. Kuo, C. M. Chan, J. H. Chen, and W. L. Chen, “The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: early risk prognostication,” The American Journal of Emergency Medicine, vol. 30, no. 5, pp. 732–736, 2012. View at Google Scholar
  72. Y.-H. Shams, “Insights into the pathogenesis of takotsubo syndrome, which with persuasive reasons should be regarded as an acute cardiac sympathetic disease entity,” ISRN Cardiology, vol. 2012, Article ID 593735, 6 pages, 2012. View at Publisher · View at Google Scholar
  73. S. A. Mayer, J. Lin, S. Homma et al., “Myocardial injury and left ventricular performance after subarachnoid hemorrhage,” Stroke, vol. 30, no. 4, pp. 780–786, 1999. View at Publisher · View at Google Scholar · View at Scopus
  74. J. G. Zaroff, G. A. Rordorf, J. S. Titus et al., “Regional myocardial perfusion after experimental subarachnoid hemorrhage,” Stroke, vol. 31, no. 5, pp. 1136–1143, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. C. King, “Listening to the head and not the heart: subarachnoid haemorrhage associated with severe acute left ventricular failure,” BMJ Case Reports, 2013. View at Publisher · View at Google Scholar
  76. H. Yoneda, T. Nakamura, S. Shirao et al., “Multicenter prospective cohort study on volume management after subarachnoid hemorrhage: Hemodynamic changes according to severity of subarachnoid hemorrhage and cerebral vasospasm,” Stroke, vol. 44, no. 8, pp. 2155–2161, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Moussouttas, E. W. Lai, K. Dombrowski et al., “CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy,” Neurocritical Care, vol. 14, no. 3, pp. 401–406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. S. A. Mayer, M. E. Fink, D. Homma et al., “Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage,” Neurology, vol. 44, no. 5, pp. 815–820, 1994. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Vannemreddy, P. Venkatesh, K. Dinesh, P. Reddy, and A. Nanda, “Myocardial dysfunction in subarachnoid hemorrhage: prognostication by echo cardiography and cardiac enzymes. A prospective study.,” Acta neurochirurgica. Supplement, vol. 106, pp. 151–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. I. A. C. van der Bilt, D. Hasan, W. P. Vandertop et al., “Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis,” Neurology, vol. 72, no. 7, pp. 635–642, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Deibert, B. Barzilai, A. C. Braverman et al., “Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 98, no. 4, pp. 741–746, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. M. B. Horowitz, D. Willet, and J. Keffer, “The use of cardiac troponin-I (cTnI) to determine the incidence of myocardial ischemia and injury in patients with aneurysmal and presumed aneurysmal subarachnoid hemorrhage,” Acta Neurochirurgica, vol. 140, no. 1, pp. 87–93, 1998. View at Publisher · View at Google Scholar · View at Scopus
  83. N. Lin, C. Cheng, Y. Lee et al., “Early activation of myocardial matrix metalloproteinases and degradation of cardiac troponin i after experimental subarachnoid hemorrhage,” Journal of Surgical Research, vol. 179, no. 1, pp. E41–E48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. J. C. Miss, A. Kopelnik, L. A. Fisher et al., “Cardiac injury after subarachnoid hemorrhage is independent of the type of aneurysm therapy,” Neurosurgery, vol. 55, no. 6, pp. 1244–1250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Radolf, N. Smoll, C. Drenckhahn, J. P. Dreier, P. Vajkoczy, and A. S. Sarrafzadeh, “Cerebral lactate correlates with early onset pneumonia after aneurysmal SAH,” Translational Stroke Research, vol. 5, no. 2, pp. 278–285, 2014. View at Google Scholar
  86. W. J. Schuiling, P. J. Dennesen, and G. J. Rinkel, “Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage,” Neurocritical Care, vol. 3, no. 1, pp. 1–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. B. K. Weir, “Pulmonary edema following fatal aneurysm rupture,” Journal of Neurosurgery, vol. 49, no. 4, pp. 502–507, 1978. View at Publisher · View at Google Scholar · View at Scopus
  88. Y. Sato, E. Isotani, Y. Kubota, Y. Otomo, and K. Ohno, “Circulatory characteristics of normovolemia and normotension therapy after subarachnoid hemorrhage, focusing on pulmonary edema,” Acta Neurochirurgica, vol. 154, no. 12, pp. 2195–2202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. S. C. Deehan and I. S. Grant, “Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine,” Intensive Care Medicine, vol. 22, no. 7, pp. 672–676, 1996. View at Publisher · View at Google Scholar · View at Scopus
  90. P. M. Vespa and T. P. Bleck, “Neurogenic pulmonary edema and other mechanisms of impaired oxygenation after aneurysmal subarachnoid hemorrhage,” Neurocritical Care, vol. 1, no. 2, pp. 157–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. H. Touho, J. Karasawa, H. Shishido, K. Yamada, and Y. Yamazaki, “Neurogenic pulmonary edema in the acute stage of hemorrhagic cerebrovascular disease,” Neurosurgery, vol. 25, no. 5, pp. 762–768, 1989. View at Publisher · View at Google Scholar · View at Scopus
  92. O. Piazza, A. Venditto, and R. Tufano, “Neurogenic pulmonary edema in subarachnoid hemorrage,” Panminerva Medica, vol. 53, no. 3, pp. 203–210, 2011. View at Google Scholar · View at Scopus
  93. H. Suzuki, T. Sozen, Y. Hasegawa et al., “Subarachnoid hemorrhage causes pulmonary endothelial cell apoptosis and neurogenic pulmonary edema in mice,” in Intracerebral Hemorrhage Research, vol. 111 of Acta Neurochirurgica Supplementum, pp. 129–132, Springer, Vienna, Austria, 2011. View at Publisher · View at Google Scholar
  94. H. Suzuki, T. Sozen, Y. Hasegawa, W. Chen, and J. H. Zhang, “Caspase-1 inhibitor prevents neurogenic pulmonary edema after subarachnoid hemorrhage in mice,” Stroke, vol. 40, no. 12, pp. 3872–3875, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. P. M. Cobelens, I. A. C. W. Tiebosch, R. M. Dijkhuizen et al., “Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage,” Critical Care, vol. 14, no. 4, article R157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Chen, Z. Zhu, D. Klebe et al., “Role of P2X purinoceptor 7 in neurogenic pulmonary edema after subarachnoid hemorrhage in rats,” PLoS ONE, vol. 9, no. 2, Article ID e89042, 2014. View at Publisher · View at Google Scholar
  97. P. Alderson, C. Gadkary, and D. F. Signorini, “Therapeutic hypothermia for head injury,” Cochrane Database of Systematic Reviews, no. 4, 2004. View at Google Scholar · View at Scopus
  98. H. Ulvi, R. Demir, R. Aygul, D. Kotan, M. Calik, and M. D. Aydin, “Effects of ischemic phrenic nerve root ganglion injury on respiratory disturbances in subarachnoid hemorrhage: An Experimental Study,” Archives of Medical Science, vol. 9, no. 6, pp. 1125–1131, 2013. View at Google Scholar
  99. T. Mutoh, K. Kazumata, S. Kobayashi, S. Terasaka, and T. Ishikawa, “Serial measurement of extravascular lung water and blood volume during the course of neurogenic pulmonary edema after subarachnoid hemorrhage: initial experience with 3 cases,” Journal of Neurosurgical Anesthesiology, vol. 24, no. 3, pp. 203–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Gruber, A. Reinprecht, H. Görzer et al., “Pulmonary function and radiographic abnormalities related to neurological outcome after aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 88, no. 1, pp. 28–37, 1998. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Ghosh, S. Dey, M. Maltenfort et al., “Impact of Hunt-Hess grade on the glycemic status of aneurysmal subarachnoid hemorrhage patients,” Neurology India, vol. 60, no. 3, pp. 283–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. N. Badjatia, M. A. Topcuoglu, F. S. Buonanno et al., “Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage,” Critical Care Medicine, vol. 33, no. 7, pp. 1603–1609, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. J. Jarhult, B. Falck, S. Ingemansson, and A. Nobin, “The functional importance of sympathetic nerves to the liver and endocrine pancreas,” Annals of Surgery, vol. 189, no. 1, pp. 96–100, 1979. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. Y. Wang, S. Y. Lin, Y. H. Chuang, W. H. Sheu, K. C. Tung, and C. J. Chen, “Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats,” Endocrinology, vol. 155, no. 4, pp. 1235–1246, 2014. View at Google Scholar
  105. S. Kumari, L. Anderson, S. Farmer, S. L. Mehta, and P. A. Li, “Hyperglycemia alters mitochondrial fission and fusion proteins in mice subjected to cerebral ischemia and reperfusion,” Translational Stroke Research, vol. 3, no. 2, pp. 296–304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. W. Feng, S. Tauhid, S. Goel, E. V. Sidorov, and M. Selim, “Hyperglycemia and outcome in intracerebral hemorrhage: from bedside to bench-more study is needed,” Translational Stroke Research, vol. 3, supplement 1, pp. 113–118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. S. M. Dorhout Mees, G. W. van Dijk, A. Algra, D. R. J. Kempink, and G. J. E. Rinkel, “Glucose levels and outcome after subarachnoid hemorrhage,” Neurology, vol. 61, no. 8, pp. 1132–1133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  108. O. Alberti, R. Becker, L. Benes, T. Wallenfang, and H. Bertalanffy, “Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage,” Clinical Neurology and Neurosurgery, vol. 102, no. 2, pp. 78–83, 2000. View at Publisher · View at Google Scholar · View at Scopus
  109. N. S. Naval, R. D. Stevens, M. A. Mirski, and A. Bhardwaj, “Controversies in the management of aneurysmal subarachnoid hemorrhage,” Critical Care Medicine, vol. 34, no. 2, pp. 511–524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. J. H. Cort, “Cerebral salt wasting,” The Lancet, vol. 263, no. 6815, pp. 752–754, 1954. View at Publisher · View at Google Scholar · View at Scopus
  111. R. A. Solomon, K. D. Post, and J. G. McMurty III, “Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm,” Neurosurgery, vol. 15, no. 3, pp. 354–361, 1984. View at Publisher · View at Google Scholar · View at Scopus
  112. M. Fujioka, K. Nishio, T. Sakaki, N. Minamino, and K. Kitamura, “Adrenomedullin in patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage,” Stroke, vol. 31, no. 12, pp. 3079–3083, 2000. View at Google Scholar · View at Scopus
  113. A. K. Vellimana, “Potential implications of HCN channel dysfunction after subarachnoid hemorrhage,” Journal of Neuroscience, vol. 32, no. 27, pp. 9117–9118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  114. M. A. Kamp, M. Dibué, T. Schneider, H. Steiger, and D. Hänggi, “Calcium and potassium channels in experimental subarachnoid hemorrhage and transient global ischemia,” Stroke Research and Treatment, vol. 2012, Article ID 382146, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. W. M. van den Bergh, A. Algra, J. W. B. van der Sprenkel et al., “Hypomagnesemia after aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 52, no. 2, pp. 276–282, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. C. M. Bradford, S. Finfer, A. O’Connor et al., “A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage,” Critical Care and Resuscitation, vol. 15, no. 2, pp. 119–125, 2013. View at Google Scholar
  117. J. S. Jeon, S. H. Sheen, G. Hwang, S. H. Kang, D. H. Heo, and Y. Cho, “Intravenous magnesium infusion for the prevention of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage,” Journal of Korean Neurosurgical Society, vol. 52, no. 2, pp. 75–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. S. M. Dorhout Mees, A. Algra, W. P. Vandertop et al., “Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebocontrolled trial,” The Lancet, vol. 380, no. 9836, pp. 44–49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. K. Kudo, T. Konta, N. Degawa et al., “Relationship between kidney damage and stroke types in Japanese patients,” Clinical and Experimental Nephrology, vol. 16, no. 4, pp. 564–569, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. B. E. Zacharia, A. F. Ducruet, Z. L. Hickman et al., “Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid hemorrhage: a single-center cohort study,” Stroke, vol. 40, no. 7, pp. 2375–2381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. G. Grassi, F. Quarti-Trevano, G. Seravalle et al., “Early sympathetic activation in the initial clinical stages of chronic renal failure,” Hypertension, vol. 57, no. 4, pp. 846–851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  122. M. P. Schlaich, F. Socratous, S. Hennebry et al., “Sympathetic activation in chronic renal failure,” Journal of the American Society of Nephrology, vol. 20, no. 5, pp. 933–939, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. S. Bruderer, B. Sasu, N. Tsvitbaum, and J. Dingemanse, “Influence of severe renal impairment on the pharmacokinetics of clazosentan,” Journal of Clinical Pharmacology, vol. 51, no. 3, pp. 413–421, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. P. Nina, G. Schisano, F. Chiappetta et al., “A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage: correlation with hunt-hess grade and outcome,” Surgical Neurology, vol. 55, no. 4, pp. 197–203, 2001. View at Publisher · View at Google Scholar · View at Scopus
  125. S. Ilveskero, S. Juvela, J. Siironen, and R. Lassila, “D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity,” Neurosurgery, vol. 57, no. 1, pp. 16–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. K. Wada, H. Makino, K. Shimada, F. Shikata, A. Kuwabara, and T. Hashimoto, “Translational research using a mouse model of intracranial aneurysm,” Translational Stroke Research, vol. 5, no. 2, pp. 248–251, 2014. View at Google Scholar
  127. D. M. Kaye, J. Lefkovits, H. Cox et al., “Regional epinephrine kinetics in human heart failure: Evidence for extra-adrenal, nonneural release,” The American Journal of Physiology: Heart and Circulatory Physiology, vol. 269, no. 1, pp. H182–H188, 1995. View at Google Scholar · View at Scopus
  128. K. E. Wartenberg and S. A. Mayer, “Medical complications after subarachnoid hemorrhage,” Neurosurgery Clinics of North America, vol. 21, no. 2, pp. 325–338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. R. L. Macdonald, B. Jaja, M. D. Cusimano et al., “SAHIT investigators—on the outcome of some subarachnoid hemorrhage clinical trials,” Translational Stroke Research, vol. 4, no. 3, pp. 286–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  130. D. A. Zygun, C. J. Doig, A. K. Gupta et al., “Non-neurological organ dysfunction in neurocritical care,” Journal of Critical Care, vol. 18, no. 4, pp. 238–244, 2003. View at Publisher · View at Google Scholar · View at Scopus
  131. J. Claassen, J. R. Carhuapoma, K. T. Kreiter, E. Y. Du, E. S. Connolly, and S. A. Mayer, “Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome,” Stroke, vol. 33, no. 5, pp. 1225–1232, 2002. View at Publisher · View at Google Scholar · View at Scopus
  132. C. S. Robertson, A. B. Valadka, H. J. Hannay et al., “Prevention of secondary ischemic insults after severe head injury,” Critical Care Medicine, vol. 27, no. 10, pp. 2086–2095, 1999. View at Publisher · View at Google Scholar · View at Scopus